论文部分内容阅读
目的探讨基于交互分析团体教育模式对慢性阻塞性肺疾病(COPD)患者疾病管理依从性和生存质量水平的影响。方法选取2016年1~6月本科收治的符合纳入标准的68名COPD患者作为研究对象,按入院顺序分为对照组和观察组,每组34名患者。对照组采用传统的常规团体健康教育模式,观察组采用交互分析团体教育模式。采用慢性阻塞性肺病评估测试(CAT)、英国医学研究会呼吸困难量表(MMRC)及COPD患者症状管理行为依从性调查表在入院时、出院后6个月时测试两组COPD患者疾病管理依从性和生存质量水平变化情况。结果两组患者入院时,症状管理行为依从性比较差异无统计学意义(P>0.05);出院6个月后,观察组患者症状管理行为依从性明显高于对照组患者,差异有统计学意义(P<0.05);入院时CAT、MMRC评分比较,差异无统计学意义(P>0.05);出院6个月后,观察组患者CAT、MMRC评分明显优于对照组患者,差异有统计学意义(P<0.05)。结论基于交互分析团体教育模式能提高COPD患者疾病管理依从性,改善患者生存质量,有利于帮助患者早日回归社会。
Objective To explore the impact of group education on the management of disease and the quality of life in patients with chronic obstructive pulmonary disease (COPD) based on the interaction analysis. Methods A total of 68 COPD patients who met the inclusion criteria admitted to our hospital from January to June 2016 were selected as study subjects and divided into control group and observation group according to admission sequence, with 34 patients in each group. The control group adopted the traditional routine group health education model, while the observation group adopted the interactive analysis group education model. CAT, BCMR, and COPD symptom management behavioral compliance questionnaire were tested at 2 months after discharge at 6 months post-discharge for disease management in both COPD patients Sexual and quality of life changes. Results There was no significant difference in symptom management behavior compliance between the two groups when hospitalized (P> 0.05). Six months after discharge, symptom management behavioral compliance in observation group was significantly higher than that in control group, the difference was statistically significant (P <0.05). There was no significant difference in CAT and MMRC scores at admission (P> 0.05). After 6 months of discharge, the scores of CAT and MMRC in the observation group were significantly better than those in the control group, the difference was statistically significant (P <0.05). Conclusion Based on the interactive analysis of group education model can improve the compliance of disease management in patients with COPD and improve the quality of life of patients is conducive to helping patients return to society as soon as possible.